Last reviewed · How we verify
Mepivacaine hydrochloride in combination with epinephrine — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Mepivacaine hydrochloride in combination with epinephrine (Mepivacaine hydrochloride in combination with epinephrine) — University of Nove de Julho.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Mepivacaine hydrochloride in combination with epinephrine TARGET | Mepivacaine hydrochloride in combination with epinephrine | University of Nove de Julho | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Mepivacaine hydrochloride in combination with epinephrine CI watch — RSS
- Mepivacaine hydrochloride in combination with epinephrine CI watch — Atom
- Mepivacaine hydrochloride in combination with epinephrine CI watch — JSON
- Mepivacaine hydrochloride in combination with epinephrine alone — RSS
Cite this brief
Drug Landscape (2026). Mepivacaine hydrochloride in combination with epinephrine — Competitive Intelligence Brief. https://druglandscape.com/ci/mepivacaine-hydrochloride-in-combination-with-epinephrine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab